Tags: Drug.
Atacicept is a recombinant fusion protein designed to inhibit B cells thereby suppressing autoimmune disease. The designer protein combines the binding site for two cytokines that regulate maturation function and survival of B cells B-lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL) with the constant region of immunoglobin.